United States Glucose Monitoring Market Outlook to 2033

Description

List of Tables

GlobalData's "United States Glucose Monitoring Market Outlook to 2033" is a comprehensive databook report, covering key market data on the United States Glucose Monitoring market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Blood Glucose Meters

The United States Glucose Monitoring Market report provides key information and data on -

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Glucose Monitoring Market.
Global corporate-level profiles of key companies operating within the United States Glucose Monitoring Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Glucose Monitoring is segmented as follows -

Blood Glucose Meters

Reasons to Buy

The United States Glucose Monitoring Market report helps you to develop -

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Product Code: GDME20105CCDB

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Glucose Monitoring Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Glucose Monitoring Market, United States

3.1 Glucose Monitoring Market, United States, Revenue ($m), 2018-2033
- 3.1.1 Blood Glucose Meters Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Glucose Monitoring Market, United States, Volume (Units), 2018-2033
- 3.2.1 Blood Glucose Meters Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Glucose Monitoring Market, United States, Average Price ($) , 2018-2033
3.4 Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2023

4 Overview of Key Companies in United States, Glucose Monitoring Market

4.1 Abbott Laboratories
- 4.1.1 Company Overview
4.2 DexCom Inc
- 4.2.1 Company Overview
4.3 Medtronic Plc
- 4.3.1 Company Overview

5 Glucose Monitoring Market Pipeline Products

6 Financial Deals Landscape

6.1 Acquisition
- 6.1.1 Cardinal Health to Acquire Advanced Diabetes Supply from Court Square Capital Partners for USD1.1 Billion.
- 6.1.2 Nova Biomedical May Sell Itself
- 6.1.3 Sumitomo Corporation of Americas (SCOA) Invests in Vast Medical Holdings
- 6.1.4 Strive Medical Acquires ProMed DME
6.2 Debt Offerings
- 6.2.1 Becton, Dickinson and Co Raises USD600 Million in Public Offering of 5.081% Notes due 2029
- 6.2.2 Becton Dickinson Raises USD1.09 Billion in Public Offering of 3.828% Notes due 2032
- 6.2.3 Johnson & Johnson Raises USD754.85 Million in Public Offering of 3.2% Notes Due 2032

7 Recent Developments

7.1 Corporate Communications
- 7.1.1 Aug 21, 2024: AGFA HealthCare Announces the UK AGFA HealthCare User Group
- 7.1.2 Aug 20, 2024: Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
- 7.1.3 Jul 05, 2024: Afamelanotide Assists DNA Repair Response Following UV Radiation
- 7.1.4 Jun 03, 2024: Kimball Electronics Appoints New Treasurer
7.2 Financial Announcements
- 7.2.1 Oct 23, 2024: Thermo Fisher Scientific Announces Q3 2024 Financial Results
- 7.2.2 Oct 10, 2024: BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results
- 7.2.3 Oct 01, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2024
- 7.2.4 Jul 25, 2024: Senseonics Holdings Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time
- 7.2.5 Jul 03, 2024: BD to Announce Financial Results for its Third Quarter of Fiscal 2024
- 7.2.6 Jul 02, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024
- 7.2.7 Jun 04, 2024: Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
- 7.2.8 May 07, 2024: Kimball Electronics Reports Q3 Results; Company Announces Renewed Strategic Focus, Including Expected Divestiture of the Automation, Test & Measurement Business
7.3 Government and Public Interest
- 7.3.1 Dec 17, 2024: Double Medical Technology Receives 510(K) Clearance For Locking Screw CoCrMo
- 7.3.2 Oct 04, 2024: Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference
- 7.3.3 Jun 03, 2024: Kimball Electronics Appoints New Treasurer
- 7.3.4 Jun 01, 2024: Typhoid Fever Vaccine "Tyfim V-I Injection Syringe" Information Regarding Obtaining Manufacturing and Sales Approval
- 7.3.5 May 27, 2024: Qurient Unveils Q901 ASCO Abstract... Verification of safety and drug response
- 7.3.6 May 21, 2024: FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
- 7.3.7 Apr 24, 2024: Merus Announces Presentation MCLA-129 at the 2024 ASCO Annual Meeting
- 7.3.8 Apr 22, 2024: Johnson & Johnson to Participate in the Bernstein's 40th Annual Strategic Decisions Conference (SDC)
- 7.3.9 Apr 04, 2024: Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
- 7.3.10 Apr 02, 2024: Johnson & Johnson to Participate in the BofA Securities Health Care Conference
- 7.3.11 Feb 14, 2024: Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference
- 7.3.12 Jan 02, 2024: Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 42nd Annual Healthcare Conference
7.4 Legal And Regulatory
- 7.4.1 Nov 12, 2024: ViiV Healthcare shares results from trial of Dovato and three-drug therapy for HIV
- 7.4.2 May 14, 2024: Valcare Medical Announces Enrollment of First Two Patients in AMEND TS EU Pilot Study
7.5 Other Significant Developments
- 7.5.1 Jun 06, 2024: LIFE Sterilization protocol ready for the production line
- 7.5.2 Feb 12, 2024: Tyber Medical Acquires FDA Clearance for Proximal Tibia Plating System
- 7.5.3 Jan 02, 2024: Senseonics Holdings Announces Business Updates
7.6 Product News
- 7.6.1 Oct 02, 2024: Rice's Biotech Launch Pad to Lead Commercialization of Bioelectrical Implant Treatment for Obesity, Type 2 Diabetes
7.7 Strategy And Business Planning
- 7.7.1 Oct 01, 2024: Glytec and Ardent Partner to Boost Diabetes and Insulin Management Nationwide
- 7.7.2 May 14, 2024: Glytec and University Hospitals (UH) Forge Strategic Partnership
- 7.7.3 Apr 18, 2024: Glytec Announces Support for Landmark New CMS Measures to Improve Diabetes Reporting

8 Appendix

8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Distribution Share Analysis
- 8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer

Product Code: GDME20105CCDB

List of Tables

Table 1: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Glucose Monitoring Market, United States, Volume (Units), 2018-2033
Table 4: Blood Glucose Meters Market, United States, Volume (Units), 2018-2033
Table 5: Glucose Monitoring Market, United States, Average Price ($), 2018-2033
Table 6: Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 7: Glucose Monitoring Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 8: Glucose Monitoring Market Pipeline Products
Table 9: Cardinal Health to Acquire Advanced Diabetes Supply from Court Square Capital Partners for USD1.1 Billion
Table 10: Nova Biomedical May Sell Itself
Table 11: Sumitomo Corporation of Americas (SCOA) Invests in Vast Medical Holdings
Table 12: Strive Medical Acquires ProMed DME
Table 13: Becton, Dickinson and Co Raises USD600 Million in Public Offering of 5.081% Notes due 2029
Table 14: Becton Dickinson Raises USD1.09 Billion in Public Offering of 3.828% Notes due 2032
Table 15: Johnson & Johnson Raises USD754.85 Million in Public Offering of 3.2% Notes Due 2032

List of Figures

Figure 1: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Glucose Monitoring Market, United States, Volume (Units), 2018-2033
Figure 4: Blood Glucose Meters Market, United States, Volume (Units), 2018-2033
Figure 5: Glucose Monitoring Market, United States, Company Share (%) 2023